Acceleron Pharma Inc. buy marge
Start price
21.06.15
/
50%
€27.02
Target price
21.12.15
€32.00
Performance (%)
49.03%
End price
21.12.15
€40.27
Summary
This prediction ended on 21.12.15 with a price of €40.27. The BUY prediction by marge for Acceleron Pharma Inc. saw massive gains of 49.03%. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Acceleron Pharma Inc. | - | - | - | - |
| iShares Core DAX® | 3,01 % | 1,44 % | 22,85 % | 50,83 % |
| iShares Nasdaq 100 | 3,01 % | 0,57 % | 37,06 % | 80,37 % |
| iShares Nikkei 225® | 4,14 % | 4,55 % | 53,86 % | 60,40 % |
| iShares S&P 500 | 2,38 % | 0,24 % | 29,01 % | 59,98 % |
Comments by marge for this prediction
In the thread Acceleron Pharma Inc. diskutieren
Acceleron Pharma
Aus meinem Langfristportofolio mit den Large-cap biotechs:
1.Gilead Science (40%)
2. Amgen (15%)
3. Celgene (25%),
und den smaller-cap biotechs:
Isis Pharmaceuticals, ChemoCentryx, Acceleron,
Portola Pharmaceuticals, Cempra, Supernus mit anteiliger Gesamtgewichtung von 20%
Nachfragen zu den einzelnen Werten beantworte ich gerne.
(Laufzeit überschritten)


